Department of Oncology, Georgetown University, Washington, DC, USA.
Cancer Prevention and Control Program, Georgetown Lombardi Comprehensive Cancer Center, 2115 Wisconsin Ave NW, Suite 300, 20007, Washington, DC, USA.
Breast Cancer Res Treat. 2023 Nov;202(2):345-355. doi: 10.1007/s10549-023-07085-w. Epub 2023 Aug 28.
Annual screening breast MRI is recommended for women at high (≥ 20% lifetime) breast cancer risk, but is underutilized. Guided by the Health Services Utilization Model (HSUM), we assessed factors associated with screening breast MRI among high-risk women.
From August 2020-January 2021, we recruited an online convenience sample of high-risk women ages 25-85 (N = 232). High-risk was defined as: pathogenic genetic mutation in self or first-degree relative; history of lobular carcinoma in situ; history of thoracic radiation; or estimated lifetime risk ≥ 20%. Participants self-reported predisposing factors (breast cancer knowledge, health locus of control), enabling factors (health insurance type, social support), need factors (perceived risk, screening-supportive social norms, provider recommendation), and prior receipt of screening breast MRI. Multivariable logistic regression analysis with backward selection identified HSUM factors associated with receipt of screening breast MRI.
About half (51%) of participants had received a provider recommendation for screening breast MRI; only 32% had ever received a breast MRI. Breast cancer knowledge (OR = 1.15, 95% CI = 1.04-1.27) and screening-supportive social norms (OR = 2.21, 95% CI = 1.64-2.97) were positively related to breast MRI receipt. No other HSUM variables were associated with breast MRI receipt (all p's > 0.1).
High-risk women reported low uptake of screening breast MRI, indicating a gap in guideline-concordant care. Breast cancer knowledge and screening-supportive social norms are two key areas to target in future interventions. Data were collected during the COVID-19 pandemic and generalizability of results is unclear. Future studies with larger, more heterogeneous samples are needed to replicate these findings.
对于乳腺癌风险较高(≥20%终身风险)的女性,建议每年进行乳房 MRI 筛查,但该检查的利用率较低。本研究以健康服务利用模型(HSUM)为指导,评估了高危女性进行乳房 MRI 筛查的相关因素。
2020 年 8 月至 2021 年 1 月,我们招募了一个在线便利样本的高危女性(年龄 25-85 岁,N=232)。高危定义为:自身或一级亲属存在致病性基因突变;有小叶原位癌病史;有胸部放疗史;或预计终身风险≥20%。参与者自我报告了促成因素(乳腺癌知识、健康控制源)、实现因素(医疗保险类型、社会支持)、需求因素(感知风险、筛查支持性社会规范、提供者推荐)以及之前是否接受过乳房 MRI 筛查。采用向后选择的多变量逻辑回归分析,确定与接受乳房 MRI 筛查相关的 HSUM 因素。
约一半(51%)的参与者曾接受过筛查乳房 MRI 的提供者推荐,但只有 32%的参与者曾接受过乳房 MRI。乳腺癌知识(OR=1.15,95%CI=1.04-1.27)和筛查支持性社会规范(OR=2.21,95%CI=1.64-2.97)与接受乳房 MRI 筛查呈正相关。其他 HSUM 变量与接受乳房 MRI 筛查无关(所有 p 值均>0.1)。
高危女性报告的乳房 MRI 筛查接受率较低,表明在遵循指南的护理方面存在差距。乳腺癌知识和筛查支持性社会规范是未来干预的两个关键领域。数据是在 COVID-19 大流行期间收集的,结果的普遍性尚不清楚。需要更大、更多样化的样本的未来研究来复制这些发现。